Investment House Lowers stake in McKesson Corporation (MCK)

McKesson Corporation (MCK) : Investment House reduced its stake in McKesson Corporation by 0.11% during the most recent quarter end. The investment management company now holds a total of 51,141 shares of McKesson Corporation which is valued at $10,070,686 after selling 55 shares in McKesson Corporation , the firm said in a disclosure report filed with the SEC on Jul 25, 2016.McKesson Corporation makes up approximately 1.54% of Investment House’s portfolio.

Other Hedge Funds, Including , Rehmann Capital Advisory Group boosted its stake in MCK in the latest quarter, The investment management firm added 54 additional shares and now holds a total of 3,467 shares of McKesson Corporation which is valued at $682,722. McKesson Corporation makes up approx 0.12% of Rehmann Capital Advisory Group’s portfolio.Capital One National Association reduced its stake in MCK by selling 3,386 shares or 23.95% in the most recent quarter. The Hedge Fund company now holds 10,749 shares of MCK which is valued at $2,133,032. McKesson Corporation makes up approx 0.17% of Capital One National Association’s portfolio.Blb&b Advisors reduced its stake in MCK by selling 133 shares or 6.24% in the most recent quarter. The Hedge Fund company now holds 2,000 shares of MCK which is valued at $396,880. McKesson Corporation makes up approx 0.07% of Blb&b Advisors’s portfolio.Chevy Chase Trust Holdings reduced its stake in MCK by selling 797 shares or 0.41% in the most recent quarter. The Hedge Fund company now holds 193,478 shares of MCK which is valued at $37,300,624. McKesson Corporation makes up approx 0.20% of Chevy Chase Trust Holdings’s portfolio.

McKesson Corporation opened for trading at $192.79 and hit $195.13 on the upside on Friday, eventually ending the session at $194.56, with a gain of 0.58% or 1.12 points. The heightened volatility saw the trading volume jump to 14,40,093 shares. Company has a market cap of $43,913 M.

On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.

Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016. McKesson Corporation was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Leave a Reply

McKesson Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on McKesson Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.